OFFERPAD SOLUTIONS INC (OPAD) Fundamental Analysis & Valuation

NYSE:OPAD • US67623L3078

Current stock price

0.8296 USD
+0.01 (+1%)
At close:
0.8381 USD
+0.01 (+1.02%)
After Hours:

This OPAD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OPAD Profitability Analysis

1.1 Basic Checks

  • OPAD had negative earnings in the past year.
  • OPAD had a positive operating cash flow in the past year.
  • In the past 5 years OPAD reported 4 times negative net income.
  • OPAD had a positive operating cash flow in 4 of the past 5 years.
OPAD Yearly Net Income VS EBIT VS OCF VS FCFOPAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M

1.2 Ratios

  • OPAD has a worse Return On Assets (-29.97%) than 80.65% of its industry peers.
  • The Return On Equity of OPAD (-121.36%) is worse than 79.03% of its industry peers.
Industry RankSector Rank
ROA -29.97%
ROE -121.36%
ROIC N/A
ROA(3y)-26.9%
ROA(5y)-19.65%
ROE(3y)-122.33%
ROE(5y)-97.27%
ROIC(3y)N/A
ROIC(5y)N/A
OPAD Yearly ROA, ROE, ROICOPAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • Looking at the Gross Margin, with a value of 8.34%, OPAD is doing worse than 70.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of OPAD has grown nicely.
  • OPAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5YN/A
OPAD Yearly Profit, Operating, Gross MarginsOPAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 5 -5 10

4

2. OPAD Health Analysis

2.1 Basic Checks

  • OPAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OPAD has been increased compared to 1 year ago.
  • OPAD has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, OPAD has an improved debt to assets ratio.
OPAD Yearly Shares OutstandingOPAD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M
OPAD Yearly Total Debt VS Total AssetsOPAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -0.98, we must say that OPAD is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.98, OPAD is doing worse than 75.81% of the companies in the same industry.
  • OPAD has a debt to FCF ratio of 1.41. This is a very positive value and a sign of high solvency as it would only need 1.41 years to pay back of all of its debts.
  • OPAD has a Debt to FCF ratio of 1.41. This is amongst the best in the industry. OPAD outperforms 83.87% of its industry peers.
  • OPAD has a Debt/Equity ratio of 2.43. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.43, OPAD is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
  • Although OPAD's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 1.41
Altman-Z -0.98
ROIC/WACCN/A
WACC9.59%
OPAD Yearly LT Debt VS Equity VS FCFOPAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M

2.3 Liquidity

  • OPAD has a Current Ratio of 1.48. This is a normal value and indicates that OPAD is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of OPAD (1.48) is comparable to the rest of the industry.
  • A Quick Ratio of 0.43 indicates that OPAD may have some problems paying its short term obligations.
  • OPAD's Quick ratio of 0.43 is on the low side compared to the rest of the industry. OPAD is outperformed by 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.43
OPAD Yearly Current Assets VS Current LiabilitesOPAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. OPAD Growth Analysis

3.1 Past

  • OPAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.42%, which is quite impressive.
  • OPAD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.20%.
  • OPAD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -47.63% yearly.
EPS 1Y (TTM)31.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.9%
Revenue 1Y (TTM)-38.2%
Revenue growth 3Y-47.63%
Revenue growth 5YN/A
Sales Q2Q%-34.52%

3.2 Future

  • Based on estimates for the next years, OPAD will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.13% on average per year.
  • Based on estimates for the next years, OPAD will show a very strong growth in Revenue. The Revenue will grow by 34.25% on average per year.
EPS Next Y54.81%
EPS Next 2Y33.69%
EPS Next 3Y19.13%
EPS Next 5YN/A
Revenue Next Year-7.65%
Revenue Next 2Y10.44%
Revenue Next 3Y6.87%
Revenue Next 5Y34.25%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPAD Yearly Revenue VS EstimatesOPAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OPAD Yearly EPS VS EstimatesOPAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8 -10

2

4. OPAD Valuation Analysis

4.1 Price/Earnings Ratio

  • OPAD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OPAD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPAD Price Earnings VS Forward Price EarningsOPAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OPAD indicates a rather cheap valuation: OPAD is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.6
EV/EBITDA N/A
OPAD Per share dataOPAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OPAD's earnings are expected to grow with 19.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.69%
EPS Next 3Y19.13%

0

5. OPAD Dividend Analysis

5.1 Amount

  • No dividends for OPAD!.
Industry RankSector Rank
Dividend Yield 0%

OPAD Fundamentals: All Metrics, Ratios and Statistics

OFFERPAD SOLUTIONS INC

NYSE:OPAD (4/28/2026, 8:04:00 PM)

After market: 0.8381 +0.01 (+1.02%)

0.8296

+0.01 (+1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners39.53%
Inst Owner Change0.01%
Ins Owners16.29%
Ins Owner Change0.25%
Market Cap39.23M
Revenue(TTM)567.81M
Net Income(TTM)-46.38M
Analysts76
Price Target1.67 (101.3%)
Short Float %11.5%
Short Ratio5.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2%
Min EPS beat(2)-9.92%
Max EPS beat(2)13.92%
EPS beat(4)3
Avg EPS beat(4)1.21%
Min EPS beat(4)-9.92%
Max EPS beat(4)13.92%
EPS beat(8)3
Avg EPS beat(8)-12.21%
EPS beat(12)5
Avg EPS beat(12)-4.53%
EPS beat(16)6
Avg EPS beat(16)-10.43%
Revenue beat(2)0
Avg Revenue beat(2)-14.37%
Min Revenue beat(2)-24.81%
Max Revenue beat(2)-3.93%
Revenue beat(4)0
Avg Revenue beat(4)-13.4%
Min Revenue beat(4)-24.81%
Max Revenue beat(4)-3.93%
Revenue beat(8)1
Avg Revenue beat(8)-8.19%
Revenue beat(12)3
Avg Revenue beat(12)-2.8%
Revenue beat(16)6
Avg Revenue beat(16)0.19%
PT rev (1m)-26.32%
PT rev (3m)-26.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 0.6
P/OCF 0.59
P/B 1.03
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)-1.55
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)1.39
FCFY167.55%
OCF(TTM)1.41
OCFY170.3%
SpS12.01
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -29.97%
ROE -121.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.34%
FCFM 11.58%
ROA(3y)-26.9%
ROA(5y)-19.65%
ROE(3y)-122.33%
ROE(5y)-97.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5YN/A
F-Score5
Asset Turnover3.67
Health
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 1.41
Debt/EBITDA N/A
Cap/Depr 110.22%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.43
Altman-Z -0.98
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)337.59%
Cap/Depr(5y)772.55%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.9%
EPS Next Y54.81%
EPS Next 2Y33.69%
EPS Next 3Y19.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.2%
Revenue growth 3Y-47.63%
Revenue growth 5YN/A
Sales Q2Q%-34.52%
Revenue Next Year-7.65%
Revenue Next 2Y10.44%
Revenue Next 3Y6.87%
Revenue Next 5Y34.25%
EBIT growth 1Y33.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.53%
EBIT Next 3Y27.26%
EBIT Next 5Y24.21%
FCF growth 1Y326.13%
FCF growth 3Y-40%
FCF growth 5YN/A
OCF growth 1Y220.69%
OCF growth 3Y-39.75%
OCF growth 5YN/A

OFFERPAD SOLUTIONS INC / OPAD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OFFERPAD SOLUTIONS INC?

ChartMill assigns a fundamental rating of 3 / 10 to OPAD.


What is the valuation status for OPAD stock?

ChartMill assigns a valuation rating of 2 / 10 to OFFERPAD SOLUTIONS INC (OPAD). This can be considered as Overvalued.


What is the profitability of OPAD stock?

OFFERPAD SOLUTIONS INC (OPAD) has a profitability rating of 1 / 10.


What is the financial health of OFFERPAD SOLUTIONS INC (OPAD) stock?

The financial health rating of OFFERPAD SOLUTIONS INC (OPAD) is 4 / 10.